[
    [
        {
            "time": "2018-03-14",
            "original_text": "智飞生物股价挫5% 股东吴冠江抛售近亿股阴云犹在",
            "features": {
                "keywords": [
                    "智飞生物",
                    "股价下跌",
                    "股东减持",
                    "吴冠江"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物股价挫5% 股东吴冠江抛售近亿股阴云犹在",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-14",
            "original_text": "【晨会聚焦】持续看好成长和消费！ 医药行业深度：抗PD-1单抗",
            "features": {
                "keywords": [
                    "医药行业",
                    "成长股",
                    "消费股",
                    "抗PD-1单抗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【晨会聚焦】持续看好成长和消费！ 医药行业深度：抗PD-1单抗",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-14",
            "original_text": "【医药】江琦、王超（联系人）：国务院机构改革为医药产业发展指明方向-20180314",
            "features": {
                "keywords": [
                    "国务院机构改革",
                    "医药产业",
                    "政策导向"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药】江琦、王超（联系人）：国务院机构改革为医药产业发展指明方向-20180314",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 5,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        }
    ]
]